Evidence map›Paper›PMID 29227287›Full record

ArticleThe Journal of clinical investigation2018

Creating a graft-friendly environment for stem cells in diseased brains.

Robert Yl Tsai

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robert Yl Tsai
Texas A&M University System · US

Funding

Aging Effect on Genome Maintenance during Hepatocyte RegenerationR21AG052006 · NIA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI TSAI, ROBERT Y · 2016 to 2017
$408k
Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular CarcinomaR03CA201988 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI TSAI, ROBERT Y · 2016 to 2017
$149k
NCI NIH HHS R03 CA201988NIA NIH HHS R21 AG052006
6 · The paper itself

Abstract

Most of the adult CNS lacks regenerative activity in terms of both neuron birth and neurite outgrowth. While this regeneration-unfriendly environment of the adult CNS may preserve the existing neuronal circuitry that takes years to develop in higher organisms, it also poses a major obstacle for CNS repair later in life. In this issue of the JCI, Song et al. report on their development of a strategy that uses region-specific and molecularly engineered astrocytes to turn an unfavorable brain environment into a favorable one for engrafted neural stem/progenitor cells (NSC/NPCs). In a rat model of Parkinson's disease (PD), cografting NPCs with midbrain-derived astrocytes engineered to overexpress the transcription factors Nurr1 and Foxa2 promotes maturation and survival of the graft, resulting in therapeutic improvement. The results of this study raise the prospect of using modified astrocytes to improve the survival, maturation, and integration of engrafted NSC/NPCs as a restorative treatment for PD.

Indexed as

Neural Stem CellsParkinson DiseaseAnimalsAstrocytesBrainDisease Models, AnimalNeuronsRats

Identifiers

PMID29227287
PMCPMC5749495
OpenAlexW2774604212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.